- Home
- NTHI vs GCTS Comparison
NTHI vs GCTS Comparison
Compare NTHI & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTHI | GCTS |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | United States |
| Employees | 5 | 126 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 93.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTHI | GCTS |
|---|---|---|
| Price | $4.33 | $2.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $15.00 | $3.50 |
| AVG Volume (30 Days) | 89.7K | ★ 4.2M |
| Earning Date | 05-19-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,052.30 |
| Revenue Next Year | N/A | $140.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.71 | $0.96 |
| 52 Week High | $12.99 | $3.93 |
Technical Indicators
Market Signals| Indicator | NTHI | GCTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.31 | 48.76 |
| Support Level | $4.17 | $1.25 |
| Resistance Level | $5.78 | $3.32 |
| Average True Range (ATR) | 0.48 | 0.30 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 7.88 | 28.64 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About GCTS GCT Semiconductor Holding Inc.
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.